WallStSmart

Fortinet Inc (FTNT)vsVivoPower PLC (VIVO)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Fortinet Inc generates 12919408% more annual revenue ($7.88B vs $61,000). FTNT leads profitability with a 29.0% profit margin vs 0.0%. FTNT earns a higher WallStSmart Score of 75/100 (B+).

FTNT

Strong Buy

75

out of 100

Grade: B+

Growth: 8.7Profit: 10.0Value: 6.7Quality: 6.0
Piotroski: 5/9Altman Z: 1.50

VIVO

Hold

36

out of 100

Grade: F

Growth: 5.3Profit: 5.0Value: 5.0Quality: 3.3
Piotroski: 3/9Altman Z: -9.98
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

FTNTUndervalued (+52.5%)

Margin of Safety

+52.5%

Fair Value

$286.50

Current Price

$136.08

$150.42 discount

UndervaluedFair: $286.50Overvalued

Intrinsic value data unavailable for VIVO.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FTNT6 strengths · Avg: 9.0/10
Return on EquityProfitability
136.7%10/10

Every $100 of equity generates 137 in profit

Operating MarginProfitability
33.8%10/10

Strong operational efficiency at 33.8%

Market CapQuality
$99.98B9/10

Large-cap with strong market position

Profit MarginProfitability
29.0%9/10

Keeps 29 of every $100 in revenue as profit

Revenue GrowthGrowth
20.5%8/10

Revenue surging 20.5% year-over-year

EPS GrowthGrowth
38.7%8/10

Earnings expanding 38.7% YoY

VIVO3 strengths · Avg: 9.3/10
Operating MarginProfitability
593000.0%10/10

Strong operational efficiency at 593000.0%

Revenue GrowthGrowth
47.6%10/10

Revenue surging 47.6% year-over-year

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Areas to Watch

FTNT3 concerns · Avg: 2.7/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

P/E RatioValuation
44.5x2/10

Premium valuation, high expectations priced in

Price/BookValuation
44.5x2/10

Trading at 44.5x book value

VIVO4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$78.38M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : FTNT

The strongest argument for FTNT centers on Return on Equity, Operating Margin, Market Cap. Profitability is solid with margins at 29.0% and operating margin at 33.8%. Revenue growth of 20.5% demonstrates continued momentum.

Bull Case : VIVO

The strongest argument for VIVO centers on Operating Margin, Revenue Growth, Price/Book. Revenue growth of 47.6% demonstrates continued momentum.

Bear Case : FTNT

The primary concerns for FTNT are Altman Z-Score, P/E Ratio, Price/Book. A P/E of 44.5x leaves little room for execution misses.

Bear Case : VIVO

The primary concerns for VIVO are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

FTNT profiles as a growth stock while VIVO is a hypergrowth play — different risk/reward profiles.

FTNT carries more volatility with a beta of 1.04 — expect wider price swings.

VIVO is growing revenue faster at 47.6% — sustainability is the question.

FTNT generates stronger free cash flow (966M), providing more financial flexibility.

Bottom Line

FTNT scores higher overall (75/100 vs 36/100), backed by strong 29.0% margins and 20.5% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Fortinet Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Fortinet (Nasdaq: FTNT) is an American multinational corporation headquartered in Sunnyvale, California. It develops and sells cybersecurity solutions, including but not limited to physical products such as firewalls, plus software and services such as anti-virus protection, intrusion prevention systems and endpoint security components.

VivoPower PLC

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Meridian Bioscience, Inc., a life sciences company, develops, manufactures, distributes and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels worldwide. The company is headquartered in Cincinnati, Ohio.

Want to dig deeper into these stocks?